Chemed CEO sells 2,000 shares at $501.40

Chemed’s president and CEO reported selling 2,000 shares and now directly holds 68,418 shares.

Available on EDGAR 09/21/2026 - 12:24 PM EDT Accepted by SEC EDGAR 09/21/2026 - 12:24 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

CHEMED CORP (CHE) reported that president and CEO Kevin J. McNamara sold 2,000 shares of Capital Stock on September 18, 2026 in an open-market or private transaction at a weighted average price of $501.40 per share, with individual trade prices ranging from $501.00 to $502.05. Following this sale, he directly holds 68,418 shares of Chemed stock, and no Rule 10b5-1 trading plan is indicated.

Insider Trade Summary

Net Seller: 2,000 shares

Net Sell 1 txn

Insider MCNAMARA KEVIN J

Role president and CEO

Sold 2,000 shs ($1.00M)

Type	Security	Shares	Price	Value
Sale	Capital Stock F1	2,000	$501.40	$1.00M

Holdings After Transaction: Capital Stock — 68,418 shares (Direct)

Footnotes (1)

1. F1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $501.00 to $502.05. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

Key Figures

Shares sold: 2,000 shares Weighted average sale price: $501.40 per share Price range of sales: $501.00–$502.05 per share +1 more

4 metrics

Shares sold 2,000 shares Capital Stock sale by CEO on September 18, 2026

Weighted average sale price $501.40 per share Average price for 2,000 shares sold on September 18, 2026

Price range of sales $501.00–$502.05 per share Range of prices across multiple transactions on September 18, 2026

Shares owned after transaction 68,418 shares Direct holdings of Kevin J. McNamara following the sale

Key Terms

weighted average price, open market or private transaction

2 terms

weighted average price financial

"The price reported in Column 4 is a weighted average price."

Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.

open market or private transaction financial

"Sale in open market or private transaction"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did CHEMED CORP (CHE) report in this Form 4?

The filing reports that president and CEO Kevin J. McNamara sold 2,000 shares of Chemed Capital Stock on September 18, 2026 in a sale classified as an open-market or private transaction.

At what price did the CHEMED CORP (CHE) CEO sell shares?

Kevin J. McNamara sold the shares at a weighted average price of $501.40 per share. A footnote explains the shares were sold in multiple transactions at prices ranging from $501.00 to $502.05.

How many CHEMED CORP (CHE) shares does the CEO own after this sale?

After the reported sale, Kevin J. McNamara directly owns 68,418 shares of Chemed Capital Stock. This figure is stated as the total number of shares directly owned following the transaction.

Was the CHEMED CORP (CHE) CEO’s stock sale under a Rule 10b5-1 trading plan?

No. The Form 4 indicates the Rule 10b5-1 checkbox is not affirmed for this filing, and the footnotes do not state that the sale was made under a Rule 10b5-1 or similar pre-arranged trading plan.

What does the weighted average price mean in the CHE Form 4 filing?

The filing states the reported $501.40 per share is a weighted average price. The shares were sold in multiple transactions between $501.00 and $502.05, and detailed trade-by-trade pricing is available from Chemed, its security holders, or SEC staff upon request.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

MCNAMARA KEVIN J

(Last) (First) (Middle)

2600 CHEMED CENTER

255 EAST 5TH STREET

(Street)

CINCINNATI OHIO 45202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CHEMED CORP [ CHE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	president and CEO

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
09/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Capital Stock	09/18/2026		S		2,000	D	$501.4(1)	68,418	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $501.00 to $502.05. The reporting person undertakes to provide to Chemed Corporation, any security holder of Chemed Corporation, or staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) of this Form 4.

	Kevin J. McNamara	09/21/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)